These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15601399)

  • 1. Addressing the epidemic of chronic kidney disease in Australia.
    Mathew T
    Nephrology (Carlton); 2004 Dec; 9 Suppl 4():S109-12. PubMed ID: 15601399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A report of the Malaysian dialysis registry of the National Renal Registry, Malaysia.
    Lim YN; Lim TO; Lee DG; Wong HS; Ong LM; Shaariah W; Rozina G; Morad Z
    Med J Malaysia; 2008 Sep; 63 Suppl C():5-8. PubMed ID: 19230240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005.
    Moist LM; Chang SH; Polkinghorne KR; McDonald SP;
    Am J Kidney Dis; 2007 Oct; 50(4):612-21. PubMed ID: 17900461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA.
    Lim WH; Johnson DW; McDonald SP
    Nephrology (Carlton); 2005 Apr; 10(2):192-7. PubMed ID: 15877681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth weight and stages of CKD: a case-control study in an Australian population.
    Al Salmi I; Hoy WE; Kondalsamy-Chennakes S; Wang Z; Healy H; Shaw JE
    Am J Kidney Dis; 2008 Dec; 52(6):1070-8. PubMed ID: 18640755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.
    Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW;
    Nephrol Dial Transplant; 2006 Mar; 21(3):776-83. PubMed ID: 16280374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and kidney disease: a big dilemma.
    Kramer H; Luke A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):237-41. PubMed ID: 17420667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced chronic kidney disease].
    Alcázar Arroyo R; Orte Martínez L; Otero González A
    Nefrologia; 2008; 28 Suppl 3():3-6. PubMed ID: 19018731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indigenous health: update on the impact of diabetes and chronic kidney disease.
    Yeates K; Tonelli M
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):588-92. PubMed ID: 17053472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment.
    Preston-Thomas A; Cass A; O'Rourke P
    Aust N Z J Public Health; 2007 Oct; 31(5):419-21. PubMed ID: 17931287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemic of chronic kidney disease in India -what can be done?
    Prabahar MR; Chandrasekaran V; Soundararajan P
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):847-53. PubMed ID: 18711313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
    Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
    J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-immunological therapy in nephropathies leading to chronic renal failure and in post-transplant chronic renal dysfunction].
    Amore A; Camilla R; Rollino C; Avenatti E; Campolo F; Peruzzi L; Conti G; Coppo R
    G Ital Nefrol; 2008; 25 Suppl 44():53-63. PubMed ID: 19048587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.
    Jafar TH
    Eur Rev Med Pharmacol Sci; 2005; 9(1):1-12. PubMed ID: 15850139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.